Elimination of pain syndrome in patients with advanced pancreatic head cancer
PDF (Русский)
DOCX

Keywords

common cancer of the pancreatic head, pain syndrome, medicamentous and endoscopic methods of pain syndrome elimination.

How to Cite

Gevorkyan, T. G., & Feinstein, I. A. (2019). Elimination of pain syndrome in patients with advanced pancreatic head cancer. Herald of Pancreatic Club, 42(1), 46-52. https://doi.org/10.33149/vkp.2019.01.07

Abstract views: 119
PDF Downloads: 231 PDF Downloads: 48

Abstract

Pain syndrome, along with mechanical jaundice, is one of the most evident clinical manifestations of pancreatic cancer and is often a sign of tumor neglecting. Existing treatment options for chronic pain in cancer patients are diverse and include the various ways of impact on the different links of pathological pain: medicinal, endoscopic, surgical. With this pathology, drug therapy using analgesics, weak and strong opioids, is usually not effective enough. In such cases, preference is given to chemical neurolysis — denervation of the autonomic structures of the retroperitoneal space, carried out under the guidance of ultrasound or computed tomography. Conducting percutaneous neurolysis of the celiac plexus with the use of alcohol or phenol is prescribed upon insufficient effectiveness of pharmacotherapy. Surgical methods of anesthesia are used extremely rarely, as they considerably worsen the patient’s condition, without significantly affecting the quality of life or the prognosis. Thoracoscopic splanchnicectomy is considered a modern and effective method of endoscopic treatment of pain in unresectable pancreatic cancer, the conduction of which can significantly decrease the intensity of pain, reduce the number of narcotic analgesics and improve the quality of life of cancer patients. This minimally invasive intervention is the basis for the subsequent lifelong systemic drug therapy.

https://doi.org/10.33149/vkp.2019.01.07
PDF (Русский)
DOCX

References

1. Камарли З. П., Туманбаев А. М., Доолотбеков С. М. Рак поджелудочной железы: эпидемиология, клиника, диагностика, лечение. ВестникКРСУ. 2013, № 1 (13). С. 117–122.
2. Кубышкин В.А., Вишневский В. А. Рак поджелудочной железы. Москва, 2003. 386 с.
3. Недолужко И. Ю., Старков Ю. Г., Шишин К. В., Кобесова Т. А. Хирургические методы лечения абдоминального болевого синдрома при нерезектабельном раке поджелудочной железы. Хирургия. 2009. № 12. С. 53–59.
4. Новикова Г. А., Осипова Н. А. Лечение хронической боли онкологического генеза. Москва, 2007. 127 с.
5. Путов Н. В., Артемьева Н. Н., Коханенко Н. Ю. Рак головки поджелудочной железы. Санкт-Петербург, 2005. 416 с.
6. Селиванова М. В. Оптимизация инвазивных методов противоболевого лечения при раке поджелудочной железы :автореф. дис. Ростов-на-Дону, 2007.
7. Силаев М. А., Важенин А. В., Бломквист Н. В., Селиванова М. В. Болевой синдром при опухолях поджелудочной железы: значение в диагностике, разновидности, возможности лечения. Проблемы клинической медицины. 2006. № 2 (6). С. 41–45.
8. Стрекаловский В. П., Буриев И. М., Гришин Н. А., и др. Торакоскопическаяспланхниксимпатэктомия при заболеваниях поджелудочной железы. Эндоскопическая хирургия. 1998. № 3. С. 59.
9. Шалимов С. А., Осинский Д. С., Черный В. А., и др. Рак поджелудочной железы: современное состояние проблемы. Киев, 2007. 316 с.
10. Cameron J. L. Pancreatic cancer. Atlas of clinical oncology. 2001. 274 p.
11. De Takatis G., Walter L., Lasner J. Splanchnic nerve section for pancreatic pain. Ann. Surg. 1949. Vol. 131. P. 44–49.
12. Eisenberg E., Carr D. B., Chalmers T. C. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth. Analg. 1995. Vol. 80. P. 290–295.
13. Flanigan D., Kraft R. Continuing experience with palliative chemical splanchnicectomy. Arch. Surg. 1978. Vol. 113. P. 509–511.
14. Gardner A., Solomou G. Relief of the pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy. Ann. Ray Coll. Surg. Engi. 1980. Vol. 62. P. 409.
15. Grimson K., Hesser F., Kitchin W. Early clinical results of transabdominal celiac and superior mesenteric ganglionectomyvagotomy, or transthoracic splanchnicoectomy in patients with chronic abdominal visceral pain. Surgery. 1947. Vol. 22. P. 230–233.
16. Hanks G. W., Conno F., Cherny N. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br. J. Cancer. 2001. Vol. 84. P. 587–593.
17. Heim M. Noninterventional study of transdermal fentanyl (fentavera) matrix patches in chronic pain patients: analgesic and quality of life effects. Pain Res. Treat. 2015. 9 p.
18. Helsey K., Dohn D. Splanchnicectomy for treatment of intractable abdominal pain. Cleve. Clin. Quart. 1987. Vol. 34. P. 9–25.
19. Hemati K., Zaman В., Hassani V., et al. Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain. Anesth. Pain Med. 2015. Vol. 5. P. e22900.
20. Ihse I., ZoucasЕ.,Gyllstedt Е. Bilateral thoracoscopicsplanchnicectomy: effects on pancreatic pain and function. AnnSurg. 1999. Vol. 230. P. 785–790.
21. Judd E., Copping J., Willix R., et al. Palliative chemical splanchnicectomy. Arch Surg. 1969.Vol. 98.Р. 418–420.
22. Kuhlmann K. F., de Castro S. M., Wesseling J. G., et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur. J. Cancer. 2004. Vol. 40. P. 549–558.
23. Kuriansky J., Saenz A., Femandez-Cruzn L. Thoracoscopicspianhmcectomy for intractable pancreatic pain. Harefuah. 1999. Vol. 137, No 11. P. 513–515.
24. Lahoud M. J., Kourie H. R., Antoun J. Road map for pain management in pancreatic cancer: a review. World J. Gastrointest. Oncol. 2016. Vol. 8, No 8. P. 599–606.
25. Le Pimpec Barthes F., Chapuis O., Riquet M. Thoracoscopicsplanhnicectomy for control of intractable pain in pancreatic cancer. Ann. Thoracic Surgery. 1998. Vol. 65. P. 810–813.
26. Levy M. J., Topazian M. D., Wiersema M. J., et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct ganglia neurolysis and block. Am.J. Gastroenterol. 2008. Vol. 103, No 1. P. 98–103.
27. Lillemoe K. D. Palliative therapy for pancreatic cancer. Surg. Oncol. Clin. 1998. Vol. 7. P. 199–216.
28. Lillemoe K., Sauter P., Pitt H. et al. Current status of surgical palliation of periampullary carcinoma. Surg. Gynecol. Obstet. 1993. Vol. 176. P. 1–10.
29. Lin C. C., Mo R. L., Lin Y. W., et al. Bilateral lower sympatheticsplanchnicectomy for upper abdominal cancer pain. Eur. J. Surg. 1994. Vol. 572. P. 59–62.
30. Melki J., Riviere J., Roullee N., et al. Thoracic splanchnectomy under video-thoracoscopy. Presse Med. 1993. Vol. 22. P. 1095–1097.
31. Patt R. B., Chiang J. S., Dai C. T. Intraspinal opioid therapy for intractable cancer pain. International anesthesiology clinics. 1998. Vol. 36, No 3. P. 105–116.
32. Penman I. D., Gilbert D. Basic technique for celiac plexus block/neurolysis. Gastrointest. Endosc. 2009. Vol. 69. P. 163–165.
33. Pietrabissa A., Vistoli F., Carobbi A., et al. Thoracoscopicsplanhnicectomy for pain relief in unresectable pancreatic cancer. Arch. Surg. 2000. Vol. 135, No 3. P. 332–335.
34. Polati E., Finco G., Gottin L. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. The British journal of surgery. 1998. Vol. 85, No 2. P. 199–201.
35. Ray B., Console A. The relief of pain in chronic pancreatitis by sympathectomy. Surg. Gynecol. Obstet. 1949. Vol. 89. P. 1–7.
36. Reber H., Foley K. Pancreatic cancer pain: presentation patthogenesis and management. J. Pain Sympt. Manage. 1988. Vol. 3. P. 163–206.
37. Sadar E. S., Cooperman A. M. Bilateral thoracic sympathectomysplanchnicectomy in the treatment of intractable pain due to pancreatic carcinoma. Cleve. Clin. Quart. 1974. Vol. 4. P. 4.
38. Sanfey H., Mendelsohn G., Cameron J. L. Soild and papillary neoplasm of the pancreas: a potentially curable surgical lesion. Ann Surg. 1983. Vol. 197. P. 272–276.
39. Sharfman W. H. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain. 1990. Vol. 41, No 3. P. 267–271.
40. Singh S., Longmire W., Reber H., et al. Surgical palliation for pancreatic cancer: the UCLA experies. Ann. Surg. 1990. Vol. 91. P. 123–133.
41. Staats P. S., Kost-Byerly S. Celiac plexus blockade in a 7-year-old child with neuroblastoma. Journal of pain and symptom management. 1995. Vol. 10, No 4. P. 321–324.
42. Takahashi T., Kakita A., Izumika H., et al. Thoracoscopicsplanhnicectomy for the relief of intractable abdominal pain. Surgical Endoscopy. 1996. Vol. 10. P. 65–68.
43. White T. T. Treatment of pancreatitis by left splanchnicectomy and celiac ganglionectomy. Am. J. Surg. 1966. Vol. 122. P. 195–198.
44. Wiersema M. J., Wiersema L. M. Endosonography-guided celiac plexus neurolysis. Gastrointest. Endosc. 1996. Vol. 44. P. 656–562.
45. Witzens-Harig M., Ho A. D., Foá R., Di Rocco A., van Hazel G., Chamone D. F. A., Rowe J. M., Arcaini L., Poddubnaya I., Ivanova V., Vranovsky A., Thurley D., Oertel S. Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase iiib maxima study. Ann.Hematol. 2014. Vol. 93, No 10. P. 1717–1724.
46. Wolfgang C. L., Herman J. M., Laheru D. A., et al. Recent progress in pancreatic cancer. Cancer J. Clin. 2013. Vol. 63. P. 318–348.
47. Wong G. Y., Schroeder D. R., Carns P. E. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004. Vol. 291. P. 1092–1099.
48. Wong G. Y., Wiersema M. G., Sarr M. G., Cameron J. L. Palliation of pain in adenocarcinoma of the pancreas. Pancreatic cancer. Atlas of clinical oncology. 2001. P. 231–244.
49. Yasuda I., Wang H. P. EUS-guided celiac plexus block and neurolysis. Dig. Endosc. 2017. Vol. 29, No 4.
50. Yochioka J., Wakabayashy T. Therapeutic neurotomy on head of pancreas for relief of pain due to chronic pancreatitis — a new technical procedure and its results. Arch. Surg. 1958. Vol. 76. P. 546–550.